Published • loading... • Updated
Insider Selling: Esperion Therapeutics (NASDAQ:ESPR) CFO Sells $33,934.95 in Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Insider Selling: Esperion Therapeutics (NASDAQ:ESPR) CFO Sells $33,934.95 in Stock
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) CFO Benjamin Halladay sold 10,773 shares of Esperion Therapeutics stock in a transaction on Wednesday, June 17th. The shares were sold at an average price of $3.15, for a total transaction of $33,934.95. Following the completion of the transaction, the chief financial officer directly owned 702,829 shares in the company, valued at $2,213,911.35. The trade was a 1.51% decrease in their o…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
